Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and overweight or obesity [ID6441]

  • In development
  • GID-TA11544
  • Expected publication date: 

26956-Semaglutide-for-Obesity-with-Cardiovascular-Disease-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)